Bobbi Bullock
Payments from drug & device makers
$609,350in general payments, 2019–2025
Across 1,010 payments — averaging $603.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$609K
- Galderma Laboratories, L.p.$405
- Revance Therapeutics, Inc.$49
General payments by program year
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 1,002 | $608,896 |
| Galderma Laboratories, L.p. | 6 | $405 |
| Revance Therapeutics, Inc. | 2 | $49 |
How this compares
$609,350 in reported general payments places this provider in the 95th percentile of 809 family providers in Idaho.
Other family in Nampa
- Alysha SchlackNampa$23K
- Kate ClarkNampa$5K
- Deo PeppersackNampa$5K
- Troy CarrNampa$4K
- Michael ParkerMeridian$69K
- Jessica BraksiekBoise$41K
- Travis BlaserBoise$33K
- Jennifer WatsonCoeur D Alene$21K
- Amber MasseIdaho Falls$17K
- Brian KittelsonMeridian$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.